Many applications including cell therapy require removing white blood cells from leukapheresis products. When performed manually, this process can be laborious and subject to user error, which leads to decreased cell recovery rates. Automated systems that use counterflow centrifugation–based technology can produce greater cell yields while retaining viability.
Download this application note from Thermo Fisher Scientific to learn
- How manual density gradient centrifugation compares to the automated Gibco™ CTS™ Rotea™ counterflow centrifugation system when separating PBMCs
- Troubleshooting tips for separating cells with the CTS Rotea system
